Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,955 total articles
Immunome (IMNM) is a clinical-stage oncology-focused antibody developer trading at $26.42 with a market cap near $3.65B. With a planned NDA submission for varegacestat and an active analyst re-rate cycle, the stock offers a high-upside, binary setup. I maintain a Strong Buy and outline an actionable swing trade with clear entry, stop and target, wh…
DoubleDown Interactive (DDI) is trading at roughly $650.7M market cap, a P/E of ~4.85 and a PB of 0.60. Recent acquisition activity, an improving technical backdrop and what looks like attractive earnings power make it a compelling tactical long. This trade lays out entry, stop and targets with time horizons and the risks to watch.
Ashland (ASH) has been in the activist spotlight since Ancora’s presentation and the board’s public engagement. The stock is trading well above its 50-day average and shows bullish technical momentum while fundamentals - including $237M in free cash flow and a $0.42 quarterly dividend - give the company optionality on buybacks, divestitures or acce…
PROG Holdings (PRG) trades at a modest multiple despite strong free cash flow, healthy ROE and a recovering consumer. This trade idea lays out a clear entry, stop and targets for a swing (mid-term) trade while spelling out the catalysts and risks that will determine whether the market re-rates the business.
Becton, Dickinson and Co. ($BDX) combines defensive consumables revenue with pockets of higher growth (syringes, diagnostics, apheresis disposables). The company prints strong cash flow and a reliable dividend, and recent market action looks like momentum after the earnings cycle. This trade targets $200 in a 45-trading-day swing with a $173 stop—a…
SK hynix has the product mix, capex discipline and AI-driven demand profile that can re-rate the company materially. I lay out an actionable long with entry at $120.00, a stop at $90.00 and a primary target of $180.00 over a 180 trading day horizon, plus intermediate targets for shorter horizons. The trade balances a clear risk plan with a bullish,…
Amazon is trading at $265 and a market cap of roughly $2.86T with P/E ~21.5 and P/S ~3.7. Fundamentals - notably AWS strength, advertising momentum and founder alignment - argue for a large incremental value opportunity (roughly $220B) over the next 12-18 months. This is a defined, medium-risk long trade: entry $265.41, stop $245.00, target $320.00…
Village Super Market (VLGEA) has retraced from spring highs while fundamentals remain intact: market cap around $573M, free cash flow of roughly $56M and a trailing P/E near 15x. The stock's pullback offers an opportunity to buy a modestly valued, dividend-paying regional grocer with upside toward $50 over the next several months, with a clear stop…
Rogers Corporation is trading well below its 52-week high after a strong recovery from last year’s trough. The market is increasingly willing to give management the benefit of the doubt on execution and margin recovery. With no net debt, positive free cash flow, and a valuation that still leaves upside if margins normalize, this is a disciplined lo…
Advanced Micro Devices is trading like a growth story that already works. Q2 results show sustained AI/data-center acceleration (roughly 50% revenue growth and >100% data-center growth), and AMD is converting that into cash. The stock is richly valued, but price has pulled back from highs and technicals are stabilizing. This trade targets a mid-ter…
IREN is a vertically integrated, renewable-powered data center operator with deep exposure to AI compute demand. The stock has retraced from $76.87 to the mid-$40s and currently trades at a market cap near $16.1B. With rumors of multibillion-dollar compute leases and a huge short base, IREN offers an asymmetric trade for patient, risk-tolerant inve…
CAVA's sales and foot-traffic recovery are showing into earnings season and the consumer-packaged goods (CPG) channel is beginning to compound revenue growth. Fundamentals and technicals align for a mid-term swing trade. Valuation is rich, but the risk/reward at current levels favors a measured long with defined stops.
Kering is showing early signs that the strategic reset at Gucci has moved from cost-cutting and repositioning to an earnings recovery. We think the market underestimates the near-term operating leverage from improving sell-through and normalized inventory levels. Enter on weakness with a clear stop and a 180-trading-day target that prices in renewe…
<p>Denali's first commercial product, AVLAYAH, validates the TransportVehicle platform and creates an immediate revenue runway. The company announced a $195 million sale of its Rare Pediatric Disease Priority Review Voucher and holds roughly $614M in cash on the balance sheet (per-share cash of $3.52 × 174.49M shares). Against a $4.43 billion marke…
H&R Block is a seasonal business with unusually predictable cash flow, a fortress-like free cash flow run-rate ($761M last reported), and an enterprise value of roughly $7.49B that implies EV/EBITDA of 7.3x. Despite a strong run YTD, the company's multiple still looks reasonable. This trade idea outlines a position-sized long with a $52.50 entry, $…
PEY (Invesco High Yield Equity Dividend Achievers ETF) is trading at $25.05 with a distribution yield of ~4.14% and a 30-day SEC yield of 4.38%. The fund is at the high end of its 52-week range but shows constructive momentum (RSI ~63, above all short-term SMAs). Heavy recent short activity creates a squeeze vector. This trade idea outlines a mid-t…
Magnera is generating healthy free cash flow and improving margin profile after the Glatfelter merger, but its equity valuation remains depressed because of high net debt. EV/EBITDA sits at 6.2 and the company produced meaningful free cash flow, creating a path for debt reduction and multiple re-rating. Trade idea: enter long at $12.20, stop at $10…
Nike's market cap sits near $60.5B after a brutal reset that pushed the stock to a $40 floor. With a 4% yield, positive free cash flow and clear operational fixes in motion, the risk/reward now favors a disciplined long—provided management continues to execute. Trade plan included for a long-term (180 trading days) directional idea with explicit en…
SpaceX sits at the intersection of secular demand for low-cost access to space and high-margin recurring revenue from global broadband. For aggressive growth traders willing to accept binary outcomes and execution risk, a tactical long with a tight stop captures upside from accelerating Starship cadence, Starlink ARPU improvements, and increasing d…
Nebius is trading at a valuation that implies near-term perfection. If the stock ever collapses to a level that values the company at roughly 5.6x next-year sales, that entry would be a compelling asymmetric trade: strong growth trends, improving EBITDA, large strategic investments from Nvidia and multi-year customer deals provide downside protecti…
CuriosityStream (CURI) popped after Q2 results that showed a rapid shift from subscriptions to AI licensing revenue. Licensing now accounts for the bulk of revenue, gross margins expanded to 73%, and management is targeting $100M in annualized sales from licensing. The market is rewarding the pivot with a large volume breakout. This trade idea fram…
PepsiCo offers a compelling risk-reward: a diversified foods-and-beverages moat, $9.28B in free cash flow, a 4.1% dividend yield, and a market cap near $191B while trading at ~18x earnings. For investors willing to hold through seasonal noise and execution risk, a long trade with defined entry, stop and target is attractive over the next 180 tradin…
Kyverna (KYTX) delivered statistically significant registrational results for miv-cel in stiff person syndrome and is preparing a BLA, yet the stock sits near $8 with a market cap roughly $537M. This trade idea outlines a long entry at $8.05, a stop at $6.00 and a target of $13.00 over a 180 trading day window, balancing the approval upside against…
Cardinal Health's recent operational signals and a board-approved dividend increase suggest the distribution and medical-products business is stabilizing after cyclic pressures. With free cash flow of $4.39B, an EV near $59.4B and valuation metrics that mix low revenue multiples with a higher P/E, the stock offers a tradeable long setup for discipl…
Cerebras' wafer-scale architecture, large 2025 revenue ramp, and recent AMD partnership set the company up to capture a disproportionate share of low-latency AI inference workloads. The stock remains volatile and richly valued, but a tactical long with a defined entry, stop and target fits a disciplined growth-at-scale thesis over the next 180 trad…
